Complete remission of minimal change disease after antiviral monotherapy in a patient with immune-active chronic hepatitis B
Tae Won Lee, Ha Nee Jang, Dae Hyun Song, Sehyun Jung, Seunghye Lee, Se-Ho Chang, Dong Jun Park · 2026
Read Complete remission of minimal change disease after antiviral monotherapy in a patient with immune-active chronic hepatitis B by Tae Won Lee, Ha Nee Jang, Dae Hyun Song, Sehyun Jung, Seunghye Lee, Se-Ho Chang, Dong Jun Park (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13680946.txt.
Description
Tae Won Lee and six colleagues report a kidney disease that vanished when only the patient's hepatitis B was treated. Minimal change disease causes heavy protein loss in urine and swelling. It is rarely linked to hepatitis B, unlike other kidney diseases the virus causes. Their patient was a forty-two-year-old woman with a week of generalized swelling and weight gain. Tests showed nephrotic-range proteinuria with normal kidney function, plus active hepatitis B.
She received antiviral monotherapy rather than the steroids usually given for this kidney condition. The kidney disease entered complete remission. The twenty twenty-six case suggests that when a virus drives the kidney problem, treating the virus alone can cure both. That spares patients steroid side effects. Single cases cannot set policy, but they flag a strategy worth testing.
Catalog record
| CREATOR | Tae Won Lee, Ha Nee Jang, Dae Hyun Song, Sehyun Jung, Seunghye Lee, Se-Ho Chang, Dong Jun Park |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |